Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 Detection in Istanbul Wastewater Treatment Plant Sludges

Bilge Alpaslan Kocamemi, Halil Kurt, Ahmet Sait, Fahriye Sarac, Ahmet Mete Saatci, Bekir Pakdemirli
doi: https://doi.org/10.1101/2020.05.12.20099358
Bilge Alpaslan Kocamemi
aMarmara University, Department of Environmental Engineering, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bilge.alpaslan@marmara.edu.tr
Halil Kurt
bSaglik Bilimleri University, International Faculty of Medicine, Department of Medical Biology, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmet Sait
cMinistry of Agriculture and Forestry, Republic of Turkey, Veterinary Control and Research Institute, Pendik, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fahriye Sarac
cMinistry of Agriculture and Forestry, Republic of Turkey, Veterinary Control and Research Institute, Pendik, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmet Mete Saatci
dTurkish Water Institute, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bekir Pakdemirli
eMinistry of Agriculture and Forestry, Republic of Turkey, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Following the announcement of SARS-CoV-2 worldwide pandemic spread by WHO on March 11, 2020, wastewater based epidemiology received great attention in several countries: The Netherlands [Medama et al., 2020; K-Lodder et al., 2020], USA [Wu et al., 2020; Memudryi et al., 2020], Australia [Ahmed et al., 2020], France [Wurtzer et al., 2020], China [Wang et al., 2020], Spain [Randazzo et al., 2020; Walter et al., 2020], Italy (La Rosa et al., 2020; Rimoldi et al., 2020) and Israel [Or et al., 2020], performed analysis in wastewaters by using different virus concentration techniques. Turkey took its place among these countries on 7th of May, 2020 by reporting SARS-CoV-2 RT-qPCR levels at the inlet of seven (7) major municipal wastewater treatment plants (WWTPs) of Istanbul [Alpaslan Kocamemi et al., 2020], which is a metropole with 15.5 million inhabitants and a very high population density (2987 persons/km2) and having about 65 % of Covid-19 cases in Turkey. Sludges that are produced in WWTPs should be expected to contain SARS-CoV-2 virus as well. There has not yet been any study for the fate of SAR-CoV-2 in sludges generated from WWTPs. Knowledge about the existing of SARS-CoV-2 in sludge may be useful for handling the sludge during its dewatering, stabilizing and disposal processes. This information will also be valuable in case of sludges that are used as soil conditioners in agriculture or sent to landfill disposal.

In wastewater treatment plants, generally two different types of sludges are generated; primary sludge (PS) and waste activated sludge (WAS). PS forms during the settling of wastewater by gravity in the primary settling tanks. Little decomposition occurs during primary sludge formation. Since most of the inorganic part of the wastewater is removed in the earlier grit removal process, the PS consists of mainly organic material that settles. The PS is about 1-2 % solids by weight. In the biological treatment part of the WWTPs, the biomass that forms in the anaerobic, anoxic and oxic zones of the process is settled in final clarifiers by gravity and returned to the beginning of the biological process so that it is not washed off. The waste activated sludge (WAS) is the excess part of the biomass that grows in this secondary treatment process. It has to be removed from the process not to increase the mixed liquor suspended solids concentration (bacteria concentration) in the secondary process more than a fixed value. The WAS is about 0.6 - 0.9 % solids by weight.

This work aims to find whether SARS-CoV-19 is present in the PS and WAS before it is dewatered and sent to anaerobic or aerobic digester processes or to thermal drying operations.

For this purpose, on the 7th of May 2020, two (2) PS samples were collected from Ambarliı and Tuzla WWTPs, seven (7) WAS samples were collected from Terkos, Ambarliı, Atakoy I & II, Pasakoy II, Buyukcekmece and Tuzla I WWTPs. Polyethylene glycol 8000 (PEG 8000) adsorption [Wu et al., 2020] SARS-Cov-2 concentration method was used for SARS-CoV-2 concentration after optimization. [Alpaslan Kocamemi et al., 2020]. Real time RT-PCR diagnostic panel validated by US was used to quantify SARS-CoV-2 RNA in primary and waste activated sludge samples taken from WWTPs in Istanbul. All samples were tested positive. Titers of SARS-CoV-2 have been detected ranging copies between 1.17×104 to 4.02×104 per liter.

Value of the Data
  • The dataset provides information about SARS-CoV-19 in primary and waste activated sludges generated in WWTPs.

  • As being the first study in the world, the dataset presented is expected to be beneficial in handling the sludge during its dewatering, stabilizing and disposal processes

Data Description SARS-CoV-2 copy numbers per liter measured for sludge samples from WWTPs were summarized in Table 1 and shown in Figure 1 together with SARS-CoV-2 copy numbers observed in an earlier study [Alpaslan Kocamemi et al., 2020] in the influent of the WWTPs from which the sludge samples were taken.

To the best of our knowledge, no study has yet been reported the presence of SARS-CoV-2 in primary sludge (PS) and waste activated sludge (WAS) samples. Herein we report the results of SARS-CoV-2 presence in two (2) PS and seven (7) WAS samples from WWTPs in Istanbul. A total of nine (9) sludge samples were collected on the 7th May of 2020 and investigated for presence of SARS-CoV-2 with RT-qPCR methodology. SARS-CoV-2 genome was detected quantitatively from all samples. Sludge samples presented CT ranging from 33.5 to 35.8. Titers of SARS-CoV-2 have been detected ranging from 1.17×104 to 4.02×104 per liter.

The detected numbers of SARS-CoV-2 in PS samples were found similar to those observed for WAS samples. SARS-CoV-2 copy numbers detected in PS and WAS on 7th of May, 2020 are greater than the copy numbers observed in the influent of these WWTPs on 21st April, 2020 [Alpaslan Kocamemi, 2020]. By considering the fact that the number of cases reported for Istanbul on the 7th of May, 2020 is less than the cases reported for the 21st April, 2020, it may be concluded that SARS-CoV-2 concentrations are more in both primary and waste activated sludge.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was financed by Republic of Turkey, Ministry of Agriculture and Forestry.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The authors confirm that the data supporting the findings of this study are available within the article.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 16, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 Detection in Istanbul Wastewater Treatment Plant Sludges
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 Detection in Istanbul Wastewater Treatment Plant Sludges
Bilge Alpaslan Kocamemi, Halil Kurt, Ahmet Sait, Fahriye Sarac, Ahmet Mete Saatci, Bekir Pakdemirli
medRxiv 2020.05.12.20099358; doi: https://doi.org/10.1101/2020.05.12.20099358
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 Detection in Istanbul Wastewater Treatment Plant Sludges
Bilge Alpaslan Kocamemi, Halil Kurt, Ahmet Sait, Fahriye Sarac, Ahmet Mete Saatci, Bekir Pakdemirli
medRxiv 2020.05.12.20099358; doi: https://doi.org/10.1101/2020.05.12.20099358

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (414)
  • Anesthesia (90)
  • Cardiovascular Medicine (857)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
  • Epidemiology (8560)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1749)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1239)
  • Health Policy (620)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10294)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (211)
  • Neurology (1677)
  • Nursing (97)
  • Nutrition (250)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (450)
  • Oncology (928)
  • Ophthalmology (263)
  • Orthopedics (101)
  • Otolaryngology (172)
  • Pain Medicine (113)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (250)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1766)
  • Public and Global Health (3835)
  • Radiology and Imaging (623)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (167)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)